I am a hematologist and oncologist specializing in the treatment of lymphomas. My research areas of intesrest include the use of T-cell engaging therapies in the treatment of hematologic malignancies, including CAR T-cell and T-cell engaging bispecific antibodies.
I went to medical school at the University of Maryland School of Medicine and completed my internal medicine residency and hematology and oncology fellowship at Brown University.
I have published on clinical trial endpoints, CAR T-cell outcomes, and bispecific antibody treatment and I am currently the co-investigator on several clinical trials at the Brown University Health Cancer Institute.
